While the G protein-mediated signaling is linked to beneficial effects (i.e. analgesia), the β-arrestin2 signaling pathway appears to be responsible for the undesirable effects (i.e. respiratory depression, constipation, tolerance and dependence) of MOR agonists. This evidence concerns the gene OPRM1 and Respiratory insufficiency due to muscle weakness.